Sakhnin, Israel

Reem Miari

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Genegrafts Ltd.. Active years: 2012.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reem Miari: Innovator in Ion Channel Research

Introduction

Reem Miari is a prominent inventor based in Sakhnin, Israel. She has made significant contributions to the field of medical research, particularly in the area of ion channels. Her work focuses on developing innovative solutions for medical conditions associated with ion channel insufficiency.

Latest Patents

Reem Miari holds a patent for "Polynucleotides and polypeptide of human KV1.3, compositions comprising same and methods of using same." This patent describes an isolated polypeptide that includes a first amino acid sequence that is at least 90% homologous to amino acid coordinates 1-398 of SEQ ID NO: 2, a tryptophan residue, and a second amino acid sequence that is at least 90% homologous to amino acid coordinates 400-523 of SEQ ID NO: 2. The patent also provides polynucleotide sequences encoding this polypeptide and outlines its uses in treating medical conditions related to ion channel insufficiency.

Career Highlights

Reem Miari is currently associated with Genegrafts Ltd., where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on medical treatments and therapies.

Collaborations

Reem collaborates with notable colleagues, including Yair Feld and Tal Bresler, who contribute to her research endeavors and help drive innovation in the field.

Conclusion

Reem Miari's contributions to the field of ion channel research exemplify her dedication to advancing medical science. Her innovative patent and ongoing work at Genegrafts Ltd. highlight her role as a key figure in the development of treatments for ion channel-related medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…